Ambev S.A. (NYSE:ABEV)’s traded shares stood at 6.47 million during the last session. At the last check today, the stock’s price was $2.76, to imply an increase of 2.80% or $0.08 in intraday trading. The ABEV share’s 52-week high remains $3.95, putting it -43.12% down since that peak but still an impressive 24.64% since price per share fell to its 52-week low of $2.08. The company has a valuation of $42.18B, with an average of 26.63 million shares in intraday trading volume over the past 10 days and average of 25.21 million shares over the past 3 months.
Analysts have given a consensus recommendation of a Hold for Ambev S.A. (ABEV), translating to a mean rating of 3.20. Of 15 analyst(s) looking at the stock, 3 analyst(s) give ABEV a Sell rating. 1 of those analysts rate the stock as Overweight while 4 advise Hold as 6 recommend it as a Buy. 1 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.03.
Ambev S.A. (NYSE:ABEV) trade information
After registering a 2.80% upside in the latest session, Ambev S.A. (ABEV) has traded red over the past five days. The stock hit a weekly high of 2.77 this Thursday, 10/07/21, jumping 2.80% in its intraday price action. The 5-day price performance for the stock is -2.90%, and -11.84% over 30 days. With these gigs, the year-to-date price performance is -12.42%. Short interest in Ambev S.A. (NYSE:ABEV) saw shorts transact 70.76 million shares and set a 2.65 days time to cover.
Analysts on Wall Street suggest a consensus price target of $3.66, implying an increase of 24.59% to the stock’s recent value. The extremes give us $2.40 and $5.00 for target low and target high price respectively. As such, ABEV has been trading -81.16% off suggested target high and 13.04% from its likely low.
Ambev S.A. (ABEV) estimates and forecasts
Looking at statistics comparing Ambev S.A. share performance against respective industry, we note that the company has underperformed competitors. Ambev S.A. (ABEV) shares are -3.25% down over the last 6 months, with its year-to-date growth rate lower than industry average at -7.14% against 19.50%. The rating firms project that company’s revenue will grow 15.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is $3.25 billion. Meanwhile, for the quarter ending Dec 2021, a total of 3 analyst(s) estimate revenue growth to $3.85 billion.Earnings reports from the last fiscal year show that sales brought in $2.33 billion and $3.44 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 39.30% before jumping 11.90% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 39.83% for the past 5-year period. While 2021 is set for a 0.00% return in earnings, projections for the next 5 years are at 7.40% annually.
Ambev S.A. has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ambev S.A. has a forward dividend ratio of 0.01, with the share yield ticking at 0.37% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 2.71%.
Ambev S.A. (NYSE:ABEV)’s Major holders
Ambev S.A. insiders hold 0.00% of total outstanding shares, with institutional holders owning 9.82% of the shares at 9.82% float percentage. In total, 9.82% institutions holds shares in the company, led by First Eagle Investment Management, LLC. As of Mar 30, 2021, the company held over 234.79 million shares (or 1.49% of shares), all amounting to roughly $643.34 million.
The next major institution holding the largest number of shares is Harding Loevner LLC with 190.28 million shares, or about 1.21% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $521.37 million.
We also have First Eagle Global Fund and Harding, Loevner Funds, Inc-International Equity Portfolio as the top two Mutual Funds with the largest holdings of the Ambev S.A. (ABEV) shares. Going by data provided on Jan 30, 2021, First Eagle Global Fund holds roughly 103.31 million shares. This is just over 0.66% of the total shares, with a market valuation of $288.23 million. Data from the same date shows that the other fund manager holds a little less at 75.46 million, or 0.48% of the shares, all valued at about 209.77 million.